Clinical Trials Directory

Trials / Completed

CompletedNCT03251040

Fibrin Sealant in Esophageal Surgery

Autologous Activated Fibrin Sealant for the Esophageal Anastomosis, a Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Amsterdam UMC, location VUmc · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Anastomotic leakage remains a major complication after esophageal surgery. Amongst other preventive measures, fibrin sealant is a promising adjunct to conventional anastomotic techniques. The investigators aimed to investigate feasibility of additional sealing by means of autologous fibrin sealant of the esophageal anastomosis.

Conditions

Interventions

TypeNameDescription
DEVICEAutologous activated fibrin sealantApplication of fibrin sealant

Timeline

Start date
2015-08-01
Primary completion
2016-04-01
Completion
2017-05-01
First posted
2017-08-16
Last updated
2017-08-22

Source: ClinicalTrials.gov record NCT03251040. Inclusion in this directory is not an endorsement.

Fibrin Sealant in Esophageal Surgery (NCT03251040) · Clinical Trials Directory